In the SURMOUNT-1 trial, which studied tirzepatide, researchers reported 6 cases of appendicitis among 1,896 participants over 84 weeks
Zheng, W., Pan, H., Wei, L., Gao, F
This is vital for those who go straight from the airport to meetings
Greater waist size decrease with Zepbound: People taking Zepbound lost an average of 18.4 centimeters around their waist, compared to 13 centimeters with Wegovy
Benefits of the Combination Therapy Patients using cagrlintide with tirzepatide may notice: Improved appetite suppression, leading to reduced caloric intake